NASDAQ: KNSA - Kiniksa Pharmaceuticals, Ltd.
Yield per half year: +53.15%
Sector: Healthcare
Reporting Kiniksa Pharmaceuticals, Ltd.
Capitalization
IFRS
Annual
Quarterly
Balance sheet
IFRS
Annual
Quarterly
Share
IFRS
Annual
Quarterly
Efficiency
IFRS
Annual
Quarterly
Coefficients
IFRS
Annual
Quarterly
Dividends
IFRS
Annual
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | LTM | Industry average | 5 year average | CAGR 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Дивиденд
|
0 | |||||||||
Див доход, ао, %
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.86 | ||
Дивиденды / прибыль, %
|
0 | 0 | 0 | 41.83 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription